Your browser doesn't support javascript.
loading
Vaccines as alternatives to antibiotics for food producing animals. Part 2: new approaches and potential solutions.
Hoelzer, Karin; Bielke, Lisa; Blake, Damer P; Cox, Eric; Cutting, Simon M; Devriendt, Bert; Erlacher-Vindel, Elisabeth; Goossens, Evy; Karaca, Kemal; Lemiere, Stephane; Metzner, Martin; Raicek, Margot; Collell Suriñach, Miquel; Wong, Nora M; Gay, Cyril; Van Immerseel, Filip.
Afiliação
  • Hoelzer K; The Pew Charitable Trusts, 901 E Street NW, Washington, DC, 20004, USA. khoelzer@pewtrusts.org.
  • Bielke L; Ohio Agriculture and Research Development Center, Animal Sciences, Ohio State University, 202 Gerlaugh Hall, 1680 Madison Ave., Wooster, OH, 44691, USA.
  • Blake DP; Pathobiology and Population Sciences, Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hertfordshire, AL9 7TA, UK.
  • Cox E; Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
  • Cutting SM; School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, TW20 0EX, UK.
  • Devriendt B; Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
  • Erlacher-Vindel E; Science and New Technologies Department, World Organisation for Animal Health (OIE), 12 Rue de Prony, 75017, Paris, France.
  • Goossens E; Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
  • Karaca K; Elanco Animal Health, 2500 Innovation Way, Greenfield, IN, USA.
  • Lemiere S; Merial, 29 Avenue Tony Garnier, 69007, Lyon, France.
  • Metzner M; RIPAC-LABOR GmbH, Am Mühlenberg 11, 14476, Potsdam, Germany.
  • Raicek M; Science and New Technologies Department, World Organisation for Animal Health (OIE), 12 Rue de Prony, 75017, Paris, France.
  • Collell Suriñach M; MSD, 2 Giralda Farms, Madison, NJ, USA.
  • Wong NM; The Pew Charitable Trusts, 901 E Street NW, Washington, DC, 20004, USA.
  • Gay C; Office of National Programs, Agricultural Research Service, USDA, Sunnyside Ave, 5601, Beltsville, MD, USA.
  • Van Immerseel F; Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Salsiburylaan 133, 9820, Merelbeke, Belgium.
Vet Res ; 49(1): 70, 2018 07 31.
Article em En | MEDLINE | ID: mdl-30060759
ABSTRACT
Vaccines and other alternative products are central to the future success of animal agriculture because they can help minimize the need for antibiotics by preventing and controlling infectious diseases in animal populations. To assess scientific advancements related to alternatives to antibiotics and provide actionable strategies to support their development, the United States Department of Agriculture, with support from the World Organisation for Animal Health, organized the second International Symposium on Alternatives to Antibiotics. It focused on six key areas vaccines; microbial-derived products; non-nutritive phytochemicals; immune-related products; chemicals, enzymes, and innovative drugs; and regulatory pathways to enable the development and licensure of alternatives to antibiotics. This article, the second part in a two-part series, highlights new approaches and potential solutions for the development of vaccines as alternatives to antibiotics in food producing animals; opportunities, challenges and needs for the development of such vaccines are discussed in the first part of this series. As discussed in part 1 of this manuscript, many current vaccines fall short of ideal vaccines in one or more respects. Promising breakthroughs to overcome these limitations include new biotechnology techniques, new oral vaccine approaches, novel adjuvants, new delivery strategies based on bacterial spores, and live recombinant vectors; they also include new vaccination strategies in-ovo, and strategies that simultaneously protect against multiple pathogens. However, translating this research into commercial vaccines that effectively reduce the need for antibiotics will require close collaboration among stakeholders, for instance through public-private partnerships. Targeted research and development investments and concerted efforts by all affected are needed to realize the potential of vaccines to improve animal health, safeguard agricultural productivity, and reduce antibiotic consumption and resulting resistance risks.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Gado Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Gado Idioma: En Ano de publicação: 2018 Tipo de documento: Article